Establishing a Safe Administration of ASA in Cardiovascular Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity with Skin and/or Respiratory Involvement

Affiliations

01 January 2018

-

doi: 10.1159/000486415


Abstract

Background: A history of nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity with cross-intolerance to several drugs is common in some patients with coronary artery disease. We present a series of patients with acute coronary syndrome undergoing ASA desensitization prior to a possible stent to evaluate the short- and long-term efficacy and safety. The aim was to evaluate the outcomes of an ASA desensitization protocol developed by our center based on the guidelines proposed by the EAACI drug allergy expert recommendations.

Methods: We developed a desensitization protocol that was based on both the patient characteristics and onset of reaction after NSAIDs, including premedication with a leukotriene antagonist and the H1-antagonist antihistamine. The clinical entities were NSAID-induced urticaria and/or angioedema in the absence of chronic spontaneous urticaria (NIUA) and NSAID-exacerbated respiratory disease (NERD).

Results: A total of 23 patients were challenged or desensitized with ASA: 19 NIUA and 4 NERD. All patients tolerated the protocol at the different times of 30, 45, 90, and 120 min. The dosages of oral ASA that were given included 10, 21, 41, 81, and 162 mg (cumulative dose 315 mg). One patient reacted during the procedure and 1 during follow-up. Symptoms were limited to the skin without manifestations in other organs. All patients tolerated the required dose of ASA within 30-120 min. Those requiring urgent catheterization were desensitized within 90 min.

Conclusions: Our protocol addresses challenge or desensitization with the contribution of a specialist allergist. It provides an effective, dynamic, safe, and short administration of 81 mg or higher of ASA in patients with a history of NSAID hypersensitivity with skin involvement.

Keywords: Challenge; Coronary angioplasty; Desensitization; High-risk patients; Nonsteroidal anti-inflammatory drugs.


Similar articles

Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease.

Cortellini G, Raiteri A, Galli M, Lotrionte M, Piscaglia F, Romano A.J Thromb Thrombolysis. 2023 May;55(4):762-769. doi: 10.1007/s11239-023-02782-1. Epub 2023 Feb 9.PMID: 36757645

Clinical approach on challenge and desensitization procedures with aspirin in patients with ischemic heart disease and nonsteroidal anti-inflammatory drug hypersensitivity.

Cortellini G, Romano A, Santucci A, Barbaud A, Bavbek S, Bignardi D, Blanca M, Bonadonna P, Costantino MT, Laguna JJ, Lombardo C, Losappio LM, Makowska J, Nakonechna A, Quercia O, Pastorello EA, Patella V, Terreehorst I, Testi S, Cernadas JR; EAACI Drug Interest Group on Challenge and Desensitization Procedures with Aspirin in CAD; Dionicio Elera J, Lippolis D, Voltolini S, Grosseto D.Allergy. 2017 Mar;72(3):498-506. doi: 10.1111/all.13068. Epub 2016 Nov 28.PMID: 27732743

Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease.

McMullan KL, Wedner HJ.Clin Cardiol. 2013 Jan;36(1):25-30. doi: 10.1002/clc.22054. Epub 2012 Sep 18.PMID: 22990948 Free PMC article.

Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema.

Kowalski ML, Woessner K, Sanak M.J Allergy Clin Immunol. 2015 Aug;136(2):245-51. doi: 10.1016/j.jaci.2015.06.021.PMID: 26254051 Review.

Aspirin and Nonsteroidal Antiinflammatory Drugs Hypersensitivity and Management.

Modena B, White AA, Woessner KM.Immunol Allergy Clin North Am. 2017 Nov;37(4):727-749. doi: 10.1016/j.iac.2017.07.008. Epub 2017 Sep 1.PMID: 28965637 Review.


Cited by

NSAID-induced reactions: classification, prevalence, impact, and management strategies.

Blanca-Lopez N, Soriano V, Garcia-Martin E, Canto G, Blanca M.J Asthma Allergy. 2019 Aug 8;12:217-233. doi: 10.2147/JAA.S164806. eCollection 2019.PMID: 31496752 Free PMC article. Review.


KMEL References